Mycobacterium Tuberculosis-IN-8
Mycobacterium Tuberculosis-IN-8 (Compound 6g) is a selective inhibitor of Mycobacterium tuberculosis (MTB) with an MIC value of 6.25 µg/mL against MTB H37Rv. Mycobacterium Tuberculosis-IN-8 shows potent antitubercular activities, inhibiting mycolic acid biosynthesis critical for bacterial cell wall integrity. Mycobacterium Tuberculosis-IN-8 is promising for research of antitubercular agents[1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
ClC1=CC=C(N2C(C3=CC=CC=C3)=C(C4=CC=CC=C4)N=C2C5=CC=C(NC6=CC=NC7=CC(Cl)=CC=C67)C=C5)C=C1Cl
Molecular Formula
C36H23Cl3N4
Molecular Weight
617.95
References & Citations
[1]Khebude N, et al. Novel quinoline–imidazole derivatives as inhibitors of Mycobacterium tuberculosis: an integrated approach combining molecular dynamics and in-vitro studies[J]. Molecular Simulation, 2025: 1-19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401135-100 1x 100 µL
P21 / WAF1 (CIP1/823 + DCS-60.2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
